Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Western

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Research Square|August 6, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisJoseph Bradley, Daniel Western, Ciyang Wang, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseasesYing Xu, Marisa N Denkinger, Menghan Liu, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJoseph Bradley, Cyril Pottier, Eder Lucio da Fonseca, et al.
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Research Square|April 1, 2025
Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and Pathways for Alzheimer's DiseaseCarlos Cruchaga, Gyujin Heo, Alvin Thomas, et al.
Nature Medicine|March 31, 2025
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's diseaseHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Research Square|August 6, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisJoseph Bradley, Daniel Western, Ciyang Wang, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseasesYing Xu, Marisa N Denkinger, Menghan Liu, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJoseph Bradley, Cyril Pottier, Eder Lucio da Fonseca, et al.
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Research Square|April 1, 2025
Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and Pathways for Alzheimer's DiseaseCarlos Cruchaga, Gyujin Heo, Alvin Thomas, et al.
Nature Medicine|March 31, 2025
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's diseaseHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.
Pageof 6